» Articles » PMID: 10966463

Protein Tyrosine Kinase Structure and Function

Overview
Publisher Annual Reviews
Specialty Biochemistry
Date 2000 Aug 31
PMID 10966463
Citations 361
Authors
Affiliations
Soon will be listed here.
Abstract

Tyrosine phosphorylation is one of the key covalent modifications that occurs in multicellular organisms as a result of intercellular communication during embryogenesis and maintenance of adult tissues. The enzymes that carry out this modification are the protein tyrosine kinases (PTKs), which catalyze the transfer of the phosphate of ATP to tyrosine residues on protein substrates. Phosphorylation of tyrosine residues modulates enzymatic activity and creates binding sites for the recruitment of downstream signaling proteins. Two classes of PTKs are present in cells: the transmembrane receptor PTKs and the nonreceptor PTKs. Because PTKs are critical components of cellular signaling pathways, their catalytic activity is strictly regulated. Over the past several years, high-resolution structural studies of PTKs have provided a molecular basis for understanding the mechanisms by which receptor and nonreceptor PTKs are regulated. This review will highlight the important results that have emerged from these structural studies.

Citing Articles

Insulin receptor responsiveness governs TGFβ-induced hepatic stellate cell activation: Insulin resistance instigates liver fibrosis.

Lee W, Bates E, Kipp Z, Pauss S, Martinez G, Blair C FASEB J. 2025; 39(5):e70427.

PMID: 40022609 PMC: 11871568. DOI: 10.1096/fj.202402169R.


Implication of protein post translational modifications in gastric cancer.

Song H, Zhang M, Guo C, Guo X, Ma Y, Ma Y Front Cell Dev Biol. 2025; 13:1523958.

PMID: 39968176 PMC: 11833226. DOI: 10.3389/fcell.2025.1523958.


Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting.

Spada A, Gerber-Lemaire S Nanomaterials (Basel). 2025; 15(3).

PMID: 39940134 PMC: 11820047. DOI: 10.3390/nano15030158.


Molecular mechanism of genetic, epigenetic, and metabolic alteration in lung cancer.

Fatima S, Kumar V, Kumar D Med Oncol. 2025; 42(3):61.

PMID: 39893601 DOI: 10.1007/s12032-025-02608-5.


Microglia in morphine tolerance: cellular and molecular mechanisms and therapeutic potential.

Zhang X, Jin T, Wang H, Han S, Liang Y Front Pharmacol. 2024; 15:1499799.

PMID: 39669194 PMC: 11635611. DOI: 10.3389/fphar.2024.1499799.